Depression Clinical Trials in New York

114 recruiting studies across 1 city

Browse by City

All Trials in New York

Phase

Trial	Phase	Sponsor	Dist.
A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Breast Cancer	N/A	Memorial Sloan Kettering Cancer Center	<1 mi
E-Mindfulness Approaches for Living After Breast Cancer	Phase 3	NRG Oncology	<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	Phase 2	Reunion Neuroscience Inc	<1 mi
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma	N/A	Memorial Sloan Kettering Cancer Center	<1 mi
DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer	N/A	Memorial Sloan Kettering Cancer Center	<1 mi
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)	Phase 2	Seaport Therapeutics	<1 mi
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder	Phase 3	Intra-Cellular Therapies, Inc.	<1 mi
Psilocybin-Assisted Therapy for Intergenerational Trauma	Phase 2	Rachel Yehuda	<1 mi
Personalized Mobile Cognitive Behavioral Therapy Application	N/A	Weill Medical College of Cornell University	<1 mi
Accelerated TMS for Depression and OCD	N/A	Weill Medical College of Cornell University	<1 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"	Phase 3	Cybin IRL Limited	<1 mi
Aβ Dynamics in LLMD	Phase 4	NYU Langone Health	<1 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder	Phase 3	Cybin IRL Limited	<1 mi
SAINT in Postpartum Depression (PPD)	N/A	Magnus Medical	<1 mi
Telephone-Based Support Programs for People With Epilepsy	N/A	NYU Langone Health	<1 mi
Engage & Connect: A Psychotherapy for Postpartum Depression	N/A	Weill Medical College of Cornell University	<1 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression	N/A	LivaNova	<1 mi
Improving the Mental Health of Home Health Aides	N/A	Weill Medical College of Cornell University	<1 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms	Phase 3	Janssen Research & Development, LLC	<1 mi
Assessment of Music Experiences in Navigating Depression Part 2	N/A	Icahn School of Medicine at Mount Sinai	<1 mi
A Digital Intervention for Post-Stroke Depression and Executive Dysfunction	Phase 2	Weill Medical College of Cornell University	<1 mi
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	<1 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms	Phase 4	Axsome Therapeutics, Inc.	<1 mi
WeCare: A System of Care for Black Youth	N/A	New York University	<1 mi
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder	Phase 2	Icahn School of Medicine at Mount Sinai	<1 mi
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression	Phase 2	Draig Therapeutics Ltd	<1 mi
Mobile Cognitive Behavioral Therapy for Stroke	N/A	Weill Medical College of Cornell University	<1 mi
Maintenance rTMS for Depression (Maitr-De)	N/A	University of California, San Diego	<1 mi
Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)	N/A	NYU Langone Health	<1 mi
Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression	Phase 2	Icahn School of Medicine at Mount Sinai	<1 mi
DBS for TRD With the Medtronic Percept PC	N/A	Helen Mayberg, MD	<1 mi
Safe Mothers, Safe Children Initiative	N/A	New York University	<1 mi
Tele-PROTECT Therapy: Effectiveness, Empowerment, and Implementation	N/A	Weill Medical College of Cornell University	<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)	Phase 3	Xenon Pharmaceuticals Inc.	<1 mi
Clinical Trial on Agitation in Alzheimer's Dementia	Phase 2	IGC Pharma, LLC	<1 mi
A Patient Activation Approach to Implementing Depression Treatment in Cardiac Patients	N/A	Columbia University	<1 mi
Mindfulness-Based fMRI Neurofeedback for Depression	N/A	Columbia University	<1 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)	Phase 2	Autobahn Therapeutics, Inc.	<1 mi
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
ROSE in Sunset Park	N/A	NYU Langone Health	<1 mi
Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33	N/A	NYU Langone Health	<1 mi
Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)	Phase 2	NYU Langone Health	<1 mi
Lay-Delivered Behavioral Activation in Senior Centers	N/A	University of Washington	<1 mi
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients	Phase 3	Intra-Cellular Therapies, Inc.	<1 mi
Harlem Strong Mental Health Coalition	N/A	City University of New York, School of Public Health	<1 mi
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder	Phase 3	Vanda Pharmaceuticals	<1 mi
WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt	N/A	Weill Medical College of Cornell University	<1 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder	Phase 2	AbbVie	<1 mi
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)	Phase 2	atai Therapeutics, Inc.	<1 mi
Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients	N/A	Icahn School of Medicine at Mount Sinai	<1 mi
Prevention of Psychological Health Problems Via Integrated Operational Support	N/A	New York University	<1 mi
Neural Circuit Effects of Ketamine in Depression	Phase 4	Icahn School of Medicine at Mount Sinai	<1 mi
Heart Rate Variability (HRV)-Guided Transcranial Direct Current Stimulation (tDCS)	N/A	NYU Langone Health	<1 mi
A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide	N/A	Ksana Health	<1 mi
Brief Interventions for Coping with Distress	N/A	Teachers College, Columbia University	<1 mi
Feasibility and Acceptability of a Novel Cognitive Behavioral Skills Mobile App for Pregnant and Postpartum Individuals	N/A	Weill Medical College of Cornell University	<1 mi
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
Pramipexole to Enhance Social Connections	Phase 2	University of California, San Diego	<1 mi
Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality	N/A	Weill Medical College of Cornell University	<1 mi
Mobile CBT for Middle Aged and Older Adults	N/A	Weill Medical College of Cornell University	<1 mi
Virtual Reality for Pain Management in Burn Patients	N/A	Weill Medical College of Cornell University	<1 mi
Biomarker-guided rTMS for Treatment Resistant Depression	Phase 3	Weill Medical College of Cornell University	<1 mi
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)	N/A	Abbott Medical Devices	<1 mi
An Exploratory Study Examining Biopsychosocial Markers of Anxiety and Depression	—	Singula Institute	<1 mi
Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)	Phase 2	NYU Langone Health	<1 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder	Phase 2	AbbVie	<1 mi
Readiness and Progress in Emotion Regulation Therapy	N/A	Teachers College, Columbia University	<1 mi
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.	Phase 2	LB Pharmaceuticals Inc.	<1 mi
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol	Phase 3	Axsome Therapeutics, Inc.	<1 mi
Neutralizing Interleukin (IL)-6	Phase 2	Icahn School of Medicine at Mount Sinai	<1 mi
A Study of Brenipatide in Adult Participants With Major Depressive Disorder	Phase 3	Eli Lilly and Company	<1 mi
Triage Survey for Psychiatry Research Eligibility	—	Adams Clinical	<1 mi
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression	Phase 2	Draig Therapeutics Ltd	<1 mi
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder	Phase 3	Janssen Research & Development, LLC	<1 mi
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)	Phase 3	Definium Therapeutics US, Inc.	<1 mi
A Study of Brief Behavioral Activation for the Treatment of Depression in Older Adult Cancer Survivors	Phase 2	Memorial Sloan Kettering Cancer Center	<1 mi
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)	Phase 2	Tonix Pharmaceuticals, Inc.	<1 mi
Pattern Separation in Major Depressive Disorder	Phase 1	Jeffrey Miller	<1 mi
tDCS: Sleep to Mood in Depression (S2M-D)	N/A	NYU Langone Health	<1 mi
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression	Phase 3	Janssen Research & Development, LLC	<1 mi
Sleep More, Stress Less: 90-Day Trial of Neuralli Mood	N/A	Efforia, Inc	<1 mi
Implementation of a Clinical Decision Support Tool for Postpartum Depression	N/A	Weill Medical College of Cornell University	<1 mi
SilverCloud as a School-Based Intervention for Vulnerable Youth	N/A	NYU Langone Health	5 mi
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response	Phase 2	ACADIA Pharmaceuticals Inc.	5 mi
Nebulized Ketamine for the Treatment of Major Depressive Disorder	Phase 3	Theresa Jacob, PhD, MPH	5 mi
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)	Phase 3	Xenon Pharmaceuticals Inc.	5 mi
Testing Adapted Self-Help Plus (SH+) for Stress and Well-Being in International Students at a U.S. University	N/A	The New School	5 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder	Phase 3	Xenon Pharmaceuticals Inc.	5 mi
DBS for Depression	Phase 1	Northwell Health	9 mi
Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression	N/A	Albert Einstein College of Medicine	12 mi
Psychiatric Outcomes of Unruptured Intracranial Aneurysms (POUIA)	N/A	Montefiore Medical Center	12 mi
Suicide Specific Rumination in Veterans	N/A	VA Office of Research and Development	12 mi
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus	N/A	Michigan State University	12 mi
Orexin Antagonism for Suicide Risk: A Proof-of-Concept Clinical Trial	Phase 2	Marianne Goodman	12 mi
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	12 mi
A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults	N/A	New York University	12 mi
Psilocybin to Treat Depression in Spinal Cord Injury	Phase 1/2	James J. Peters Veterans Affairs Medical Center	12 mi
OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum Depression	N/A	Hackensack Meridian Health	12 mi
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.	Phase 3	AbbVie	12 mi
Study of ALTO-300 in MDD	Phase 2	Alto Neuroscience	13 mi
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	16 mi
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	16 mi
ALTO-207 in Adults With Treatment-resistant Depression (TRD)	Phase 2	Alto Neuroscience	16 mi
Transcranial Direct Current Stimulation for Depression	N/A	Soterix Medical	18 mi
Neural and Psychiatric Consequences of Cannabis Use in Adolescents	N/A	University of Miami	23 mi
Mind-Body Skills Group for Graduate Students	N/A	Weill Medical College of Cornell University	26 mi
A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD	N/A	Weill Medical College of Cornell University	26 mi
ENA-001 for Opioid Induced Respiratory Depression	Phase 1	Enalare Therapeutics Inc.	29 mi
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	37 mi
External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy	—	Cefaly Technology	38 mi
Foundational Programs to Combat Clinician Stress	N/A	Lancaster General Hospital	41 mi
Combination of Novel Therapies for CKD Comorbid Depression	Phase 2	Stony Brook University	48 mi
PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.	Phase 4	Stony Brook University	48 mi
The Role of mGluR5 in CBT-I	Phase 4	Stony Brook University	48 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.